Implementation of the guidelines for the introduction of new drugs (GINF) in Andalusian hospitals;Implantación de la guía para la incorporación de nuevos fármacos (GINF) en los hospitales andaluces

Farmacia Hospitalaria

Volumn 31, Issue 4, 2007, Pages 212-217

  Marín Gil, Roberto ^a   Santos Ramos, B ^a   Briones Perez De La Blanca E ^b   Flores Moreno, S ^c   Gallego Villanueva, S ^a   Bautista Paloma, J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c Andalusian Agency for Health Technology Assessment Spain   (Spain)

Author keywords

Data collection; Drug evaluation; Health policy; Pharmacy and Therapeutics Committee

Indexed keywords

ARTICLE; DRUG INFORMATION; DRUG RESEARCH; GEOGRAPHY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEALTH SURVEY; MEDICAL EDUCATION; PHARMACIST; PRACTICE GUIDELINE; QUESTIONNAIRE;

EID: 36348941046     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(07)75376-X     Document Type: Article

References (21)

1. Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: The fourth hurdle. BMJ 2004; 329: 972-5.
2. Meneu R, Márquez S. La incertidumbre sobre la efectividad y seguridad de los fármacos. Relevancia de los estudios de utilización de medicamentos. Farm Hosp 2005; 29: 221-4.
3. Mather DB, Sullivan SD, Augenstein D, Fullerton DS, Atherly D. Incorporating clinical outcomes and economic consequences into drug formulary decisions: A practical approach. Am J Manag Care 1999; 5: 277-85.
4. Pausjenssen AM, Singer PA, Detsky AS. Ontario's formulary committee: how recommendations are made. Pharmacoeconomics 2003; 21: 285-94.
5. Neumann PJ. The arrival of economic evidence in managed care formulary decisions. Med Care 2005; 43: II27-II32.
6. Bautista FJ, Muñoz N, Gordillo E, Santos B, Cobos FJ, Guerrero D. Evaluación del tratamiento farmacológico del infarto de miocardio en los hospitales públicos andaluces. Med Clin (Barc) 1998; 111: 329-35.
7. Cobos FJ, Camean M, Santos B, Bautista FJ, Tarín MJ, Muñoz M, et al. Utilización de antimicrobianos en los hospitales públicos de Andalucía: 1995-1996. Farm Hosp 1997; 21: 272-81.
8. Gebran JJ. Variations in institutional pharmaceutical formularies. Institute of Health Economics, Working Paper 01-05. Edmonton, Alberta, Canada; 2001.
9. Exposito J, Hernandez J, Fernandez Feijo A, Nieto T, Briones E. New chemotherapy treatments in advanced cancer patients: an easily applicable evaluation of clinical efficacy and cost-effectiveness. Acta Oncol 2003; 42: 895-902.
10. Landis NT. NCQA draft accreditation standards for 2000 address formularies. National Committee for Quality Assurance. Am J Health Syst Pharm 1991; 56: 846.
11. Langley PC. Meeting the information needs of drug purchasers: the evolution of formulary submission guidelines. Clin Ther 1999; 21: 768-87.
12. Fry RN, Avey SG, Sullivan SD. The Academy of Managed Care Pharmacy Format for Formulary Submissions: An evolving standard - a Foundation for Managed Care Pharmacy Task Force report. Value Health 2003; 6: 505-21.
13. Neumann PJ. Evidence-based and value-based formulary guidelines. Health Aff (Millwood) 2004; 23: 124-34.
14. O'Brien BJ. Academy of Managed Care Pharmacy Format: Relevance, rigor, regulation, and realism. Value Health 2003; 6: 501-2.
15. Commonwealth Department of Health, Housing and Community Services.Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee (Internet). Canberra: Australian Government Printing Service, 1992. (acceso 20 de agosto de 2006). Disponible en: www.health.gov.au/pbs/pharm/pubs/guidelines/content.htm
16. Agencia de Evaluación de Tecnologías Sanitarias de Andalucía. Guía para la Incorporación de Nuevos Fármacos. Apoyo a la toma de decisiones en los hospitales del Sistema Sanitario Público de Andalucía (Internet). Versión 2.0. Sevilla: AETSA; 2004 (acceso 2 de septiembre de 2006). Disponible en: www.juntadeandalucia.es/salud/org-dep/aetsa/pdf/Guia%20GINF%20v2.pdf
17. Servicio Andaluz de Salud. Contrato Programa de los hospitales del Servicio Andaluz de Salud 2005-2008. Sevilla: Consejería de Salud. Junta de Andalucía; 2005.
18. Flores S, Gallego S, Gil MV, Marín R, Santos B, Briones E. Similitud en la cumplimentación de las guías GINF en una muestra de hospitales españoles. Farm Hosp 2007; 31: 129-31.
19. Castellano MM, Santos B, Briones E, Villegas R, Bautista FJ. Estudio de la implantación de una guía de incorporación de nuevos medicamentos en un hospital. Rev Calidad Asistencial 2004; 19: 312-8.
20. Balekdjian D, Russo M. Managed care mandate: show us the value. Pharmaceutical Executive 2003; Sept: 80-8.
21. Academy of Managed Care Pharmacy. The AMCP Format for Formulary Submissions (Internet). Version 2.1. 2005. Alexandria, VA: AMCP, Abril 2005 (acceso 12 de junio de 2006). Disponible en: www.fmcpnet.org/data/resource